Rapt Therapeutics (RAPT)'s Technical Outlook is Bright After Key Golden Cross

Group 1 - Rapt Therapeutics (RAPT) has recently experienced a "golden cross" event, indicating a potential bullish breakout as its 50-day simple moving average has crossed above its 200-day simple moving average [1][2] - The golden cross pattern typically suggests a positive trend reversal, starting from a price decline, followed by the shorter moving average crossing above the longer one, and finally maintaining upward momentum [2][3] - RAPT has seen a rally of 9.5% over the past four weeks and currently holds a 2 (Buy) rating on the Zacks Rank, suggesting it may be poised for further gains [4] Group 2 - There have been two upward revisions in RAPT's earnings expectations over the past 60 days, with no downward changes, indicating a positive sentiment among investors [4][6] - The Zacks Consensus Estimate for RAPT has also moved up, reinforcing the bullish outlook for the company [4][6]